Cystadane
- Product NDC
- 52276-401
- 11-digit product format
- 522760401
- Labeler code
- 52276
- Product ID
- 52276-401_66ab8f97-8ea6-dc62-e053-2a91aa0adaf0
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- betaine
- Dosage form
- POWDER, FOR SOLUTION
- Route
- ORAL
- Labeler
- Orphan Europe SARL
- Marketing category
- UNAPPROVED DRUG FOR USE IN DRUG SHORTAGE
- Marketing start
- 2018-01-08
- Marketing end
- 0000-00-00
- Substance
- BETAINE
- Active strength
- 1 g/g
- Pharmacologic classes
- Methylating Activity [MoA],Methylating Agent [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2020-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 52276-401-01 | Cystadane | 180 g in 1 BOTTLE | POWDER, FOR SOLUTION | 180 | | 4 |
| 52276-401-01 | Cystadane | 1 in 1 CARTON | POWDER, FOR SOLUTION | 1 | | 4 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 52276-401 | CYSTADANE (BETAINE) POWDER, FOR SOLUTION [ORPHAN EUROPE SARL] | 4 | Legacy NDC, 2 package rows | 20180305_6053d4d2-5967-19e0-e053-2991aa0a819a.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Status |
|---|
| 52276-401-01 | 52276040101 | 180 g in 1 BOTTLE | 180 g | Historical |